Spermatogenesis is an androgen-dependent process and polymorphisms in genes encoding androgen-metabolizing enzymes may be associated with impaired male fertility. The enzyme steroid 5α-reductase converts testosterone into dihydrotestosterone. We analyzed genotype frequencies of five single nucleotide polymorphisms (SNPs 1-5) (rs632148, rs523349, rs2300701, rs2268797, and rs12470143) in the steroid 5α-reductase type 2 gene (SRD5A2) in 132 azoospermic or oligozoospermic and 211 normozoospermic men. We found no association between investigated genotypes and the occurrence of male infertility. Linear regression analysis revealed a significant correlation between certain alleles of SNP1 and SNP5 and testicular volume among control men. Normozoospermic men carrying the minor allele of all but SNP5 polymorphism exhibited a significantly higher proportion of progressively motile spermatozoa, compared with major homozygotes. However, SRD5A2 genotypes did not influence sperm concentration, serum testosterone, or follicle-stimulating hormone levels in controls. In conclusion, our results suggest that polymorphisms examined in SRD5A2 exhibit no adverse effect on semen parameters in Estonian men.
Introduction
Steroid 5α-reductase is a key enzyme involved in testosterone metabolism that converts testosterone into the more active metabolite, dihydrotestosterone (DHT). During male development, DHT is necessary for differentiation of the prostate and external genitalia. In postpuberty, DHT is the main androgen responsible for spermatozoan maturation in the epididymis (Robaire and Viger 1995) . Human 5α-reductase activity is provided by type 1 (SRD5A1) and type 2 (SRD5A2) isozymes (Jenkins et al, 1991; Labrie et al, 1992) , which exhibit partially overlapping expression patterns. Both isozymes are expressed in the prostate (Berthaut et al, 1997) and in the adult epididymis but levels of type 2 isozyme are higher (Mahony et al, 1998) .
However, SRD5A1 is expressed mainly in skin, while SRD5A2 is the only form detected in the male external genitalia and seminal vesicles (Thigpen et al, 1993; Eicheler et al, 1994) . In addition, testicular 5α-reductase activity has been detected in spermatogonia (Eicheler et al, 1994) and intact seminiferous tubules (Payne et al, 1973) . Thus, 5α-reduced activity has been presumed to be necessary for maintenance of normal spermatogenesis (Payne et al, 1973) .
The SRD5A2 gene is on chromosome 2 and is composed of 5 exons (Labrie et al, 1992; Thigpen et al, 1992) . Several studies have shown that the mutations reducing or eliminating enzymatic activity of SRD5A2 cause deficient virilization of the male external genitalia or even pseudohermaphrodism (Can et al, 1998; Chavez et al, 2000; Fernandez-Cancio et al, 2004) . The majority of these cases involve homozygous missense mutations, which lead to severe masculinization defects Mazen et al, 2003) . Although most of the affected individuals are oligozoospermic or azoospermic, normal fertility has also been reported in men without cryptorchidism (reviewed in Imperato-McGinley and Zhu 2002) . Interestingly, a previous study of mutation rates in patients affected by azoospermia and oligozoospermia failed to detect mutations in the SRD5A2 coding region (Hines et al, 1999 ). However, it remains possible that common polymorphisms in the SRD5A2 gene could contribute to male infertility. Several missense polymorphisms in the SRD5A2 gene have been shown to affect enzyme activity (Makridakis et al, 2000) . The most extensively examined single nucleotide polymorphism (SNP) involves a valine to leucine substitution at codon 89 (V89L). This alteration causes an approximately 30% reduction in enzyme activity in Asian populations (Makridakis et al, 1997) but not in men of European origin (Allen et al, 2001; Hayes et al, 2007) . In contrast, a less common missense polymorphism at codon 49, which substitutes an alanine with a threonine at codon 49 (A49T), leads to greatly enhanced enzyme activity (Ross et al, 1998) . Polymorphisms altering other amino acids of SRD5A2, however, are detected at a very low frequency (Makridakis et al, 2000) .
Recently, a new SNP tagging method has been developed that enables description of the all common genetic variation of a gene within a population with greatly reduced SNP genotyping (Johnson et al, 2001 ). Here, we investigated the frequency distribution of five tagging SNPs (tagSNPs) representing genetic variation across the entire SRD5A2 gene in 132 patients with idiopathic azoospermia or oligozoospermia. For comparison, we used 211 control normozoospermic men, to enable identification of associations between genetic variations in the SRD5A2 gene and male infertility. Additionally, the relationships between polymorphisms in SRD5A2 and fertility parameters in normozoospermic Estonian men were evaluated.
Materials and Methods

Study subjects
A total of 132 infertile men, with the infertility period of more than 12 months, visiting Andrology Unit of Tartu University Hospital in 2005 and 2006 were enrolled in this study. The mean age of patients was 31.8 ± 5.6 (SD) years and they were diagnosed either with nonobstructive azoospermia (n = 36) or oligozoospermia (n = 96, with a sperm count of 0.01 -14.0 × 10 6 /mL). As a control group, 211 men (18.7 ± 1.6 years of age) under compulsory medical examination for military service (Jensen et al, 2004) The mean sperm concentration (± SD) was 1.8 ± 2.5 × 10 6 /mL among all patients and 149.2 ± 88.0 × 10 6 /mL among controls (t-test, P < 0.001). Abstinence from ejaculation was 4.0 ± 1.6 days in the patient group and 5.2 ± 2.4 days in controls (t-test, P < 0.001). Mean testicular volume was markedly smaller (18.7 ± 7.1 mL) among patients than in controls (26.6 ± 4.9 mL, t-test, P < 0.001). Sperm motility parameters were collected from 90 oligozoospermic patients and 209 controls (mean progressive motility 20.0 ± 17.4% and 57.8 ± 9.9%, respectively. P < 0.001).
SNP selection
The pair-wise algorithm of the Tagger program was used to select tagSNPs (de Bakker et al, 2005) . Five tagSNPs across the 56 kb of the SRD5A2 gene were selected using Caucasian population data available in the HapMap database (http://www.hapmap.org). An r 2 of 0.9 was selected as a threshold (the mean r 2 of captured alleles was 0.96), enabling prediction of genotypes for 17 SNPs. SNPs with low frequency (< 5%) were excluded, as these variants could not be accurately captured with tagSNPs (Montpetit et al, 2006) . TagSNP1 (rs632148) is located within the 5' UTR of the SRD5A2 gene, tagSNP2 (rs523349) in exon 1, conferring an amino acid change V89L and remaining tagSNPs (tagSNP3 -rs2300701, tagSNP4 -rs2268797, and tagSNP5 -rs12470143) were located in intron 1 (Figure) .
Genotyping
Genomic DNA was isolated from the peripheral EDTA-blood using a salting-out method (Aljanabi and Martinez 1997) . PCR was carried out in a total volume of 15 μl, with 50 ng DNA, 0.2 mM dNTPs, 2.5 mM MgCl 2 , 1 × PCR buffer (Solis BioDyne, Tartu, Estonia), 10 pmol primers, and 0.8 U Hot Start thermostable DNA polymerase HOT FIREPol (Solis BioDyne).
Reaction mixtures were preheated (95°C, 10 min), followed by 35 cycles of amplification (95°C for 30 s, 51-63°C for 30 s, and 72°C for 30 s). Restriction fragment length polymorphism analysis was performed to detect polymorphic variants of tagSNPs. PCR primer sequences and restriction enzymes (MBI Fermentas, Vilnius, Lithuania) used are listed in Table 1 . PCR products, as well as the restriction fragments, were detected on 2% agarose gel containing 10 µg/mL ethidium bromide and were visualized by UV transillumination.
Statistical analysis
All statistical analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA) for Windows (Microsoft Corp., Redmond, WA, USA). A t-test was used to compare fertility parameters between study groups. Genotypes at each SNP were tested for Hardy-Weinberg equilibrium (HWE) using the χ 2 test. The association between the SRD5A2 genotypes and male infertility was tested with the χ 2 test, as the effects of potential confounding factors estimated by generalized linear models with logistic link function were absent and statistically not significant.
The general linear models incorporating the effects of age and length of abstinence were used to describe the associations between the SRD5A2 genotypes and fertility parameters (sperm count and motility, serum hormones, and testicular volume). P values < 0.05 were considered statistically significant. Haploview 4.0 (http://www.broad.mit.edu/mpg/haploview) program was used to calculate linkage disequilibrium (LD) between each pair-wise combinations of all SNPs (Barrett et al, 2005) . The linkage disequilibrium coefficient (D′) and r 2 were used to indicate the strength of LD. Haplotypes were inferred using program PHASE 2.1 (Stephens et al, 2001 ).
Results
SRD5A2 genotype frequencies among study groups
The genotype frequencies of five tagSNPs in the SRD5A2 gene were determined for 132 infertile patients and 211 normozoospermic control individuals. The distribution of genotypes was consistent with HWE for cases and controls, and for cases and controls combined (all P > 0.2).
We examined the distribution of SRD5A2 genotypes, by comparing the number of individuals homozygous for the major allele and the number of those carrying at least one copy of the minor allele ( Table 2) . We found no associations between the genotypes and the risk for male infertility.
Moreover, factoring in potential confounding parameters, such as patient age, length of abstinence, or degree of the severity of the fertility impairment (azoo or oligozoospermia) also failed to reveal a link between genotype and infertility (data not shown).
The results from linkage disequilibrium analysis showed that D′ for 5 tagSNPs investigated ranged from 0.45 to 0.95, with the strongest LD observed between SNP1 and SNP2
(D′ = 0.95), forming a single haplotype block (Figure) . Haplotype analysis predicted the presence of 4 major haplotypes (of 25 inferred haplotypes), with a prevalence of over 5% accounting for 82% of all haplotypes (Table 3) . Although the frequency of the most common haplotype 1 was higher among controls, while haplotype 2, composed of minor alleles of all studied tagSNPs except SNP5, was more frequent in infertile patients, the differences were not statistically significant.
SRD5A2 genotypes and clinical parameters among normozoospermic controls
Linear models adjusted by age showed that the SNP1 C-allele (GC+CC versus GG genotype) and SNP5 T-allele (CT+TT versus CC genotype) were associated with smaller (25.8 versus 27.3 mL, P = 0.024) and larger (27.0 versus 25.4 mL, P = 0.036) mean testicular volumes, respectively (Table 4 ). Linear models adjusted by age and the length of abstinence revealed that the proportion of progressively motile category A and B type of spermatozoa was significantly higher among subjects carrying at least one copy of the minor allele (variant homozygotes and heterozygotes) for all polymorphisms investigated, except SNP5 (mean 59-60% versus 56% for wild-type homozygotes, P = 0.009, 0.010, 0.008 and 0.010 for SNP1 to 4, respectively). The inverse trend was observed for the proportion of immotile (category D) spermatozoa (P = 0.016, 0.018, 0.008 and 0.005 for SNP1 to 4, respectively). However, no marked relationship between the SRD5A2 genotype and non-progressive category C type motility was observed among normozoospermic men (Table 4 ). In addition, our results indicated a lack of correlation between genotypes investigated and semen volume, sperm count, and serum hormones (T and FSH) (data not shown).
Discussion
We examined the possible role of 5 common SRD5A2 gene SNPs in predisposition to male infertility, and their association with semen parameters. Our results indicate that normozoospermic men carrying at least one minor allele of all but SNP5 polymorphism had a significantly higher proportion of progressively moving spermatozoa, while all other semen and hormonal parameters were independent of genetic variation examined at the SRD5A2 locus. In addition, we found no genetic link between SRD5A2 and severe male infertility due to azoospermia or oligozoospermia.
Analysis of the role of 5α-reductase in spermatogenesis has been limited. Recent studies have
shown that use of dutasteride and finasteride (a dual inhibitor of type 1 and type 2 enzyme and a specific inhibitor of type 2 enzyme, respectively) suppresses serum DHT levels significantly, while having only a mild (Amory et al, 2007) or no effect on sperm concentration (Overstreet et al, 1999) . Some study participants responded to treatment with 5α-reductase inhibitors, by exhibiting around a 10% reduction in total sperm count. Although not formally demonstrated, genetic differences have been assumed to be one of the most likely reason for this variable intersubject response (Amory et al, 2007) . Furthermore, treatment of fertile men with testosterone enanthate in a male contraceptive study led to development of azoospermia in 50-70% of patients, while the rest remained oligozoospermic (Anderson et al, 1996) . The variation in response to testosterone enanthate has been suggested to be related to intrinsic differences in 5α-reductase activity (Anderson et al, 1996; Anderson et al, 1997 ) possibly owing to polymorphisms in the 5α-reductase gene (Elzanaty et al, 2006 ).
According to public genome databases, more than 300 SNPs mostly in non-coding regions have been detected in the SRD5A2 gene, but only a few of these have been functionally validated. The most thoroughly examined polymorphism is a C to G transversion at codon 89. The G-allele (L) of V89L (SNP2 in the present study) has been shown to cause reduced activity of the SRD5A2 enzyme in vitro (Makridakis et al, 2000) . The prevalence of the L-allele is different among ethnic groups being particularly common in Asian populations where the LL-genotype has been found to be associated with approximately 30% lower SRD5A2 activity (Makridakis et al, 1997) .
However, in men of European origin the association between the V89L polymorphism and SRD5A2 activity was insignificant (Febbo et al, 1999; Allen et al, 2001; Hayes et al, 2007) and no conclusive evidence of V89L polymorphism affecting serum hormone levels is present (Ntais et al, 2003) . Given that SRD5A2 is abundantly expressed in the adult prostate (Levine et al, 1996) , the V89L polymorphism has been extensively examined in relation to prostate cancer (e.g. Loukola et al, 2004; Giwercman et al, 2005; Lindstrom et al, 2007) . However, recent large studies do not support associations between V89L and the risk of prostate cancer (Pearce et al, 2002; Hayes et al, 2007) .
To date, only one study has investigated the influence of SRD5A2 polymorphisms on sperm parameters. In this study, no correlation between V89L polymorphism and sperm count was found among healthy Caucasians but individuals carrying AT-genotype of the polymorphism A49T exhibited markedly higher sperm concentration compared to AA homozygotes (Elzanaty et al, 2006) . Our results are concordant as we did not detect significant differences in V89L
genotype distribution between infertile patients and controls, nor between genotypes and sperm count among normozoospermic men. Here, however, we did not examine A49T variation, since the frequency of the T-allele is too low to be used in tagSNP selection.
Spermatozoa acquire progressive motility during migration through the epididymis (reviewed in Cornwall 2009 ). Normal epididymal functions are dependent upon DHT (Robaire and Viger 1995) . SRD5A2 is expressed abundantly throughout the adult epididymis (Mahony et al, 1998) , and seminal DHT is of primarily epididymal origin (Anderson et al, 1997) . Furthermore, the examination of epididymal sperm maturation following treatment with dual 5α-reductase inhibitor in rats has been shown to reduce the number of the motile sperm (Henderson and Robaire 2005) , thus indicating a role of SRD5A2 activity in gaining sperm motility. On the contrary, reduction of SRD5A2 activity with finasteride failed to affect semen parameters other than seminal volume in young men (Overstreet et al, 1999 , Steers 2001 . The lack of effect on semen parameters has been proposed to be caused by SRD5A1 activity in germinal epithelium (Steers 2001) . Nonetheless, a recent study using of finasteride and dutasteride revealed a small but significant reduction on semen volume and sperm motility in normal men during treatment and follow-up (Amory et al, 2007) . Thus, variation in the SRD5A2 gene may influence sperm motility parameters. The only study exploring the association between SRD5A2 polymorphisms and sperm motility parameters was conducted within a Swedish population (Elzanaty et al, 2006) . Accordingly, the V-allele of the V89L confers a higher proportion of progressive (motility categories A and B) and rapidly progressive (category A) motile spermatozoa than the minor L-variant. Surprisingly, we found an inverse association between the SRD5A2 genotypes and sperm motility. Our results suggest that the minor allele of all investigated SNPs (including the L-allele of V89L but not SNP5) was associated with a small but marked rise in the proportion of progressively motile spermatozoa and a lower proportion of immotile spermatozoa among normozoospermic men. In some cases, however, the male pseudohermaphrodites with inherited 5α-reductase type 2 enzyme deficiency and thereby decreased DHT production maintain normal sperm concentration and motility (Cai et al, 1994) , suggesting that lower enzyme activities and DHT concentrations affect semen parameters dependent on prostate functions, like semen volume, but may be sufficient for normal spermatogenesis. Still, our results should be interpreted with caution, as there is no clear mechanism explaining how genetic variants associated with moderately decreased enzyme activity or intronic polymorphisms with unknown function would lead to an increased proportion of progressive sperm motility.
Testicular size correlates with testicular function and fertility, being predictive of sperm count and motility as well as serum levels of reproductive hormones (FSH, luteinizing hormone and T) (Takihara et al, 1987) . Our results suggest that there is an association between the SNP1 C-allele (GC and CC genotypes) and SNP5 T-allele (CT and TT genotypes) with smaller and larger testicular volume, respectively. The C-allele of SNP1 and the T-allele of SNP5 were over-and underrepresented, respectively, among our infertile patients' group, though these findings were not statistically significant. However, the main androgenic steroid in the testicular environment is testosterone as its local concentration is much higher than that of DHT (Zhao et al, 2004) .
Therefore, further studies are warranted to confirm the validity of our results.
We did not find any relationship between SRD5A2 allelic variants and serum levels of reproductive hormones among controls. These results are consistent with previous findings (Elzanaty et al, 2006) . In that study authors supposed that the studied polymorphisms did not affect DHT level in serum. Hence, it is unlikely that these polymorphisms also influence the concentrations of other reproductive hormones. Moreover, it has also been shown that the treatment of healthy men with 5α-reductase inhibitors causes no significant changes in their serum gonadotropin levels (Overstreet et al, 1999 , Amory et al, 2007 .
Conclusion
This is the first case-control study, to our knowledge, that has examined the role of the SRD5A2 polymorphisms in development of idiopathic male infertility. Our data suggest that common genetic variations in the SRD5A2 gene are not related to the occurrence of idiopathic azoospermia and oligozoospermia in the Estonian population. Nevertheless, a moderate increase in the proportion of progressively motile spermatozoa was found in normozoospermic men carrying at least one minor allele of all but one of the polymorphisms investigated. 
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* F and R indicate, respectively, forward and reverse primers. The nucleotides modified to create specific restriction sites are underlined. Sperm motility A+B † % 56.1 (9.6) 59.6 (9.9) ‡ 56.1 (9.7) 59.6 (9.9) ‡ 55. Figure 1 , Peters et al.
